Earnings History Data for Endo International (ENDP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Endo International

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2022	PM	(Aug 9)	ENDP	Endo International	168.00	0.03	-0.16	0.00	Endo Non-GAAP EPS of -$0.03 beats by $0.11, revenue of $569.11M beats by $44.54M [8/9/2022 8:52 AM]	0.4018	-0.27 (-39.85%)	0.0	0.0 (0.00%)	0.28 - 7.07	109,569,329	46,420,000	0
Endo Non-GAAP EPS of -$0.03 beats by $0.11, revenue of $569.11M beats by $44.54M [8/9/2022 8:52 AM] Endo epilepsy therapy cenobamate gets Health Canada review [8/9/2022 9:52 AM] New Drug Filing for Cenobamate Accepted for Review in Canada and Israel [Aug-09-22 09:00AM] ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS [Aug-09-22 08:45AM] Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy [Aug-08-22 04:30PM] Endo International (ENDP) Tops Q2 Earnings and Revenue Estimates [Aug-09-22 10:05AM] Drugmaker Endo Says Bankruptcy Likely Imminent [Aug-09-22 09:32AM]
05-05-2022	AH	4:15 PM ET (May 5)	ENDP	Endo International plc	507.15	0.66	0.44	0.73	Endo Non-GAAP EPS of $0.66 beats by $0.22, revenue of $652.26M beats by $15.17M [5/5/2022 4:37 PM]	1.42	-0.60 (-29.95%)	1.35	-0.67 (-33.17%)	1.28 - 7.07	17,500,422	6,240,000	1,493,267
Endo Non-GAAP EPS of $0.66 beats by $0.22, revenue of $652.26M beats by $15.17M [5/5/2022 4:37 PM] Endo crashes on disappointing 2Q guidance [5/6/2022 7:47 AM] Endo cut to Underweight at Piper Sandler with $1 price target [5/6/2022 12:57 PM] Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More [May-04-22 03:19PM] ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS [May-05-22 04:30PM] Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting [May-05-22 04:15PM] Endo International (ENDP) Surpasses Q1 Earnings and Revenue Estimates [May-05-22 07:15PM] Why Endo International Stock Is Cratering Today [May-06-22 12:16PM] Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results [May-06-22 01:23PM]
28-02-2022	AH	4:15 PM ET (Feb 28)	ENDP	Endo International plc	722.04	0.84	0.70	0.75	Endo Non-GAAP EPS of $0.84 beats by $0.16, revenue of $784.4M beats by $50.43M [2/28/2022 4:22 PM]	2.38	-0.73 (-23.56%)	2.94	-0.17 (-5.47%)	1.94 - 8.74	12,533,371	3,570,000	102,777
Endo Non-GAAP EPS of $0.84 beats by $0.16, revenue of $784.4M beats by $50.43M [2/28/2022 4:22 PM] Endo down 6% in post market despite earnings beating on top and bottom lines [2/28/2022 5:25 PM] Endo loses legal defenses in Tennessee opioid trial [3/1/2022 12:57 PM] ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS [Feb-28-22 04:15PM] Endo (ENDP) Surpasses Q4 Earnings and Revenue Estimates [Mar-01-22 11:19AM] Why Shares of Endo International Slumped 22.8% on Tuesday [Mar-01-22 04:45PM]
04-11-2021	AH	4:15 PM ET (Nov 4)	ENDP	Endo International plc	1,080	0.80	0.46	0.52	Endo EPS beats by $0.31, beats on revenue [11/4/2021 4:27 PM]	6.18	1.24 (25.10%)	5.34	0.40 (8.10%)	1.94 - 10.89	50,638,300	6,070,000	180,575
Endo EPS beats by $0.31, beats on revenue [11/4/2021 4:27 PM] Endo gains 5% after hours following full-year 2021 guidance lift, Q3 earnings beat [11/4/2021 5:51 PM] Drug, Biotech Stock Q3 Earnings on Nov 4: MRNA, REGN & More [Nov-03-21 11:04AM] Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance [Nov-04-21 04:15PM] Endo International (ENDP) Q3 Earnings and Revenues Surpass Estimates [Nov-04-21 08:56PM] Endo International Plc (ENDP) Q3 2021 Earnings Call Transcript [Nov-05-21 11:01AM] Endo (ENDP) Beats Q3 Earnings & Sales Estimates, Raises View [Nov-05-21 10:43AM]
05-08-2021	AH	4:15 PM ET (Aug 5)	ENDP	Endo International plc	1,080	0.65	0.42	0.65	Endo EPS beats by $0.16, beats on revenue [8/5/2021 4:38 PM]	4.30	-0.39 (-8.32%)	4.92	0.23 (4.90%)	2.71 - 10.89	7,995,906	4,830,000	12,963
Endo Announces Execution of Definitive Settlement Agreement and Release Resolving Tennessee State Court Case [Aug-04-21 07:30AM] Endo Reports Second-Quarter 2021 Financial Results And Updates 2021 Financial Guidance [Aug-05-21 04:15PM] Endo International (ENDP) Q2 Earnings and Revenues Beat Estimates [Aug-05-21 08:45PM] Endo International Plc (ENDP) Q2 2021 Earnings Call Transcript [Aug-06-21 11:01AM]
06-05-2021	AH	4:30 PM ET (May 6)	ENDP	Endo International plc	1,280	0.73	0.48	0.95	Endo EPS beats by $0.25, beats on revenue [5/6/2021 4:35 PM]	5.64	0.21 (3.78%)	5.66	0.23 (4.24%)	2.71 - 10.89	3,614,293	2,980,000	7,665
Endo EPS beats by $0.25, beats on revenue [5/6/2021 4:35 PM] Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance [May-06-21 04:15PM] Endo International (ENDP) Tops Q1 Earnings and Revenue Estimates [May-06-21 08:20PM] Endo International plc (ENDP) Q1 2021 Earnings Call Transcript [May-07-21 12:31PM] Endo's (ENDP) Earnings & Revenues Surpass Estimates in Q1 [May-07-21 12:17PM]
25-02-2021	AH	4:50 PM ET (Feb 25)	ENDP	Endo International plc	2,260	0.75	0.50	0.74	Endo EPS beats by $0.27, beats on revenue [2/25/2021 4:31 PM]	7.93	-1.38 (-14.82%)	8.97	-0.34 (-3.65%)	2.08 - 10.89	8,229,764	3,494,575	97,290
Endo EPS beats by $0.27, beats on revenue [2/25/2021 4:31 PM] Endo posts Q4 beat on Sterile Injectables strength [2/25/2021 4:51 PM] Endo International cut to strong sell at CFRA citing pressure on growth [2/26/2021 3:11 PM] Endo International plc (ENDP) Q4 2020 Earnings Call Transcript [Feb-26-21 12:31PM] Endo's (ENDP) Earnings & Revenues Surpass Estimates in Q4 [Feb-26-21 12:09PM]
05-11-2020	AH	4:30 PM ET (Nov 5)	ENDP	Endo International plc	1,020	0.52	0.14	0.60	Endo EPS beats by $0.38, beats on revenue, raises FY20 guidance [11/5/2020 5:02 PM]	4.45	-0.42 (-8.62%)	4.94	0.07 (1.44%)	2.08 - 7.10	8,875,365	4,785,477	190,605

05-08-2020	AH	4:15 PM ET (Aug 5)	ENDP	Endo International plc	799.37	0.65	0.35	0.52	Endo EPS beats by $0.31, beats on revenue [8/5/2020 4:32 PM]	3.50	-0.11 (-3.03%)	3.53	-0.08 (-2.22%)	1.97 - 7.10	2,666,448	3,754,725	12,914